Evidence map›Paper›PMID 32848725›Full record

ArticleFrontiers in pharmacology2020

Kuijieyuan Decoction Improved Intestinal Barrier Injury of Ulcerative Colitis by Affecting TLR4-Dependent PI3K/AKT/NF-κB Oxidative and Inflammatory Signaling and Gut Microbiota.

Baohai Liu, Xuehua Piao, Wei Niu, Qingyu Zhang, Chi Ma, Tong Wu, QiChang Gu, Tingfang Cui, Shuangdi Li

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 1 pooled it
14.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 1 synthesis or guideline pooled it, 151 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Protective effects ofFrontiers in microbiology · 2026
    Article
  10. Article
  11. 3 Biotech · 2025
    Article
  12. Article
  13. Spent Hop (Cells · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Protective effects ofCytotechnology · 2025
    Article
  20. Treatment-Related Mechanisms of Tibetan MedicineAnimals : an open access journal from MDPI · 2025
    Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Baohai LiuDepartment of Gastroenterology, The First Affiliated Hospital, Jinzhou Medical University, Jinzhou, China.
Xuehua PiaoDepartment of Traditional Chinese Medicine, The First Affiliated Hospital, Jinzhou Medical University, Jinzhou, China.
Wei NiuDepartment of Gastroenterology, The First Affiliated Hospital, Jinzhou Medical University, Jinzhou, China.
Qingyu ZhangDepartment of Gastroenterology, The First Affiliated Hospital, Jinzhou Medical University, Jinzhou, China.
Chi MaDepartment of Gastroenterology, The First Affiliated Hospital, Jinzhou Medical University, Jinzhou, China.
Tong WuDepartment of Gastroenterology, The First Affiliated Hospital, Jinzhou Medical University, Jinzhou, China.
QiChang GuDepartment of Gastroenterology, The First Affiliated Hospital, Jinzhou Medical University, Jinzhou, China.
Tingfang CuiDepartment of Gastroenterology, The First Affiliated Hospital, Jinzhou Medical University, Jinzhou, China.
Shuangdi LiHeart Disease Center, The Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, China.
Jinzhou Medical University · CNChangchun University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ethnopharmacological relevanceIn Traditional Chinese medicine (TCM) theory, ulcerative colitis (UC) is associated with damp-heat, blood stasis, and intestinal vascular ischemia. Kuijieyuan decoction (KD) is a traditional Chinese medicine based on the above theory and used clinically to alleviate UC injury.

methodsThe main components of KD were analyzed by using high-pressure liquid chromatography (HPLC) and confirmed by UPLC-MS/MS. A UC model was established in rats by using dextran sulfate sodium (DSS) and dead rats (caused by DSS) were excluded from the study. Forty-eight rats were divided into 6 groups, health control (CG), UC model (UG), sulfasalazine (SG), low-dose KD (LG), middle-dose KD (MG), and high-dose KD (HG) groups. UC damage was assessed by hematoxylin and eosin staining and scan electron microscopy. We measured Toll-like receptor 4 (TLR4), p-phosphatidylinositol 3-kinase (PI3K), PI3K, p-Protein kinase B (AKT), AKT, p-nuclear factor kappa B (NF-κB), NF-κB, oxidative stress marker (superoxidase dismutase (SOD), catalase (CAT), glutathione peroxidases (GPx), and malondialdehyde) and inflammatory markers (tumor necrosis factor α (TNFα), interleukin (IL)-1, IL-6 and IL-10) in UC tissues. Gut microbiota was analyzed through16S rRNA sequencing.

resultsThe main components of KD consist of gallic acid, paeoniflorin, emodin, berberine, coptisine, palmatine, jatrorrhizine, baicalein and baicalin. The UC model was successfully established by causing intestinal barrier injury with the loss of intestinal villi and destructed mitochondria of intestinal epithelial cells. Both sulfasalazine and KD treatment repaired UC injury, reduced the levels of malondialdehyde, TNFα, IL-1, IL-6, TLR4, p-PI3K, p-AKT, and p-NF-κB, and increased the levels of SOD, GPx, CAT, and IL-10. KD showed a protective function for the UC model in a dose-dependent way. The serum levels of paeoniflorin and baicalin had a strong relationship with the levels of inflammatory and oxidative stress biomarkers. KD treatment increased the proportion of Alloprevotella, Treponema, Prevotellaceae, and Prevotella, and reduced the proportion of Escherichia_Shigella and Desulfovibrio in gut microbiota.

conclusionsKD improved intestinal barrier injury of ulcerative colitis, antioxidant and anti-inflammatory properties by affecting TLR4-dependent PI3K/AKT/NF-κB signaling possibly through the combination of its main compounds, and improving gut microbiota.

Indexed as

anti-inflammatoryantioxidantgut microbiotaKuijieyuan decoctionTLR4-dependent PI3K/AKT/NF-κB signalingulcerative colitis

Identifiers

PMID32848725
PMCPMC7403404
OpenAlexW3045561650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.